Domenico Galetta, Medical oncologist at IRCCS Giovanni Paolo II, shared a post on X:
“Very interesting and intense discussion on the role of neoadjuvant vs perioperative chemo-immunotherapy.
There is still no definitive consensus, many questions remain open, but a new path is now fully achievable.”
More posts featuring RomeLung25
